SMDAM
TEVA icon

Sumitomo Mitsui DS Asset Management’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Sumitomo Mitsui DS Asset Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.97M Buy
117,183
+106
+0.1% +$3.53K 0.03% 392
2026
Q1 		$3.53M Hold
117,077
– – 0.03% 398
2025
Q4 		$3.65M Hold
117,077
– – 0.03% 383
2025
Q3 		$2.36M Sell
117,077
-179
-0.2% -$3.14K 0.02% 473
2025
Q2 		$1.97M Hold
117,256
– – 0.02% 508
2025
Q1 		$1.8M Buy
117,256
+11,912
+11% +$213K 0.02% 511
2024
Q4 		$2.32M Buy
105,344
+332
+0.3% +$6.04K 0.02% 451
2024
Q3 		$1.89M Sell
105,012
-163
-0.2% -$2.85K 0.02% 493
2024
Q2 		$1.71M Buy
105,175
+9,903
+10% +$153K 0.02% 482
2024
Q1 		$1.34M Buy
95,272
+10,087
+12% +$127K 0.02% 537
2023
Q4 		$889K Sell
85,185
-337
-0.4% -$3.15K 0.01% 635
2023
Q3 		$872K Buy
85,522
+290
+0.3% +$2.7K 0.01% 589
2023
Q2 		$642K Sell
85,232
-489
-0.6% -$3.96K 0.01% 646
2023
Q1 		$759K Buy
85,721
+8,341
+11% +$82.5K 0.01% 602
2022
Q4 		$706K Hold
77,380
– – 0.01% 591
2022
Q3 		$624K Buy
77,380
+8,305
+12% +$73.4K 0.01% 591
2022
Q2 		$519K Buy
69,075
+14,597
+27% +$127K 0.01% 620
2022
Q1 		$512K Sell
54,478
-12,606
-19% -$105K 0.01% 656
2021
Q4 		$537K Buy
67,084
+9,782
+17% +$88.3K 0.01% 658
2021
Q3 		$558K Sell
57,302
-440
-0.8% -$4.12K 0.01% 640
2021
Q2 		$571K Sell
57,742
-4,689
-8% -$49.6K 0.01% 650
2021
Q1 		$720K Buy
62,431
+6,873
+12% +$78.8K 0.02% 564
2020
Q4 		$536K Sell
55,558
-2,747
-5% -$26.3K 0.02% 600
2020
Q3 		$525K Sell
58,305
-148
-0.3% -$1.57K 0.02% 564
2020
Q2 		$720K Sell
58,453
-5,275
-8% -$59.7K 0.02% 476
2020
Q1 		$572K Buy
63,728
+2,938
+5% +$30.1K 0.02% 469
2019
Q4 		$595K Buy
60,790
+4,252
+8% +$38K 0.02% 563
2019
Q3 		$388K Buy
56,538
+460
+0.8% +$3.52K 0.01% 599
2019
Q2 		$517K Sell
56,078
-5,672
-9% -$68.4K 0.02% 548
2019
Q1 		$968K Buy
61,750
+5,707
+10% +$101K 0.02% 526
2018
Q4 		$864K Sell
56,043
-4,217
-7% -$86.5K 0.02% 498
2018
Q3 		$1.3M Sell
60,260
-1,187
-2% -$27.6K 0.02% 462
2018
Q2 		$1.49M Buy
61,447
+4,310
+8% +$87.9K 0.02% 419
2018
Q1 		$976K Sell
57,137
-1,880
-3% -$36.7K 0.01% 523
2017
Q4 		$1.12M Sell
59,017
-5,994
-9% -$90.2K 0.02% 488
2017
Q3 		$1.14M Sell
65,011
-3,387
-5% -$76.2K 0.02% 441
2017
Q2 		$2.27M Sell
68,398
-881
-1% -$27.3K 0.04% 321
2017
Q1 		$2.22M Buy
69,279
+7,021
+11% +$240K 0.04% 326
2016
Q4 		$2.26M Buy
62,258
+37,017
+147% +$1.48M 0.04% 297
2016
Q3 		$1.16M Sell
25,241
-4,282
-15% -$223K 0.03% 400
2016
Q2 		$1.48M Buy
29,523
+7,507
+34% +$400K 0.05% 319
2016
Q1 		$1.18M Buy
+22,016
New +$1.29M 0.04% 360

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Sumitomo Mitsui DS Asset Management's TEVA Position: Q2 2026 in Review

Sumitomo Mitsui DS Asset Management increased its Teva Pharmaceutical Industries Limited (TEVA) stake by 0.09% in Q2 2026, buying an estimated $3.53K and bringing the position to 117,183 shares worth $3.97M. The position accounts for 0.03% of the portfolio, ranked #392.

Sumitomo Mitsui DS Asset Management first reported a position in TEVA in Q1 2016 and has held it in 42 quarters since. 676 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Sumitomo Mitsui DS Asset Management held 117,183 shares of Teva Pharmaceutical Industries Limited worth $3.97M as of Q2 2026.
  • Sumitomo Mitsui DS Asset Management bought 106 Teva Pharmaceutical Industries Limited shares in Q2 2026, an estimated $3.53K.
  • Teva Pharmaceutical Industries Limited made up 0.03% of Sumitomo Mitsui DS Asset Management's portfolio in Q2 2026, its #392 holding.
  • Sumitomo Mitsui DS Asset Management first reported a position in Teva Pharmaceutical Industries Limited in Q1 2016 and has held it in 42 quarters since.
  • 676 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2026.

Based on Sumitomo Mitsui DS Asset Management's 13F filing for Q2 2026, filed 22 Jul 2026.